chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Dizziness, Injection site induration, Injection site swelling, Pain in extremity
Clinical narrative: felt dehydrated; pain in the arm; but it was still hard; arm swelling where she got the injection; Dizziness; This is a spontaneous report from a contactable consumer reporting for herself.  A 26-year-old female patient received first dose BNT162B2 (Pfizer product, lot number EH9899), via an unspecified route of administration on 17Dec2020 06:00 at single dose on left arm for COVID-19 immunization. There were no medical history and concomitant medications. No prior vaccinations (within 4 weeks); no adverse events following prior vaccinations. The patient reported that she was the unit secretary in the hospital. She got the first dose COVID vaccine yesterday (17Dec2020 06:00). Vaccination facility type was hospital; vaccine was not administered at military facility. She was reading the paper they gave her at work. She had arm swelling where she got the injection, it had gone down a little, but it was still hard. She also felt dizziness and dehydrated. The dizziness started about an hour ago (on 18Dec2020). Since laying down it had improved a little. She has felt dehydrated since around 11am (18Dec2020 11:00). She was sipping on Gatorade, but still felt dehydrated. She took a Tylenol today (18Dec2020) for the pain in the arm and swelling. She had gone to the website and it didn't say what to do about the side effects besides call #.  She didn't think she needs to call # for a swollen arm. Therapeutic measures were taken as a result of arm swelling where she got the injection, pain in the arm and felt dehydrated. The adverse events did not require a visit to emergency room or physician office. The outcome for events arm swelling where she got the injection and Dizziness was resolving while for other events was unknown.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: ringing in his ear on the left; This is a spontaneous report from a contactable Physician(patient).  The 37-year-old male patient received first dose of vaccine BNT162B2(Batch/lot number: EK7530, Expiration date: unknown), via an unspecified route of administration on 18Dec2020 at single dose for prevention of Covid.  Medical history included gastrooesophageal reflux disease(GERD).  Concomitant medication included omeprazole for GERD.  The patient stated in the hospital, he had the Covid vaccine 2 hours ago and he just want to report a possible side effects, about hour after the vaccine he had ringing in his ear on the left on 18Dec2020. No treatment was received. It was not that bad. It was improving. Outcome of event was recovering.
Sex: U
Vaccine: COVID19
Symptoms: Injection site pain, Pyrexia
Clinical narrative: soreness at injection site at hour 3; low grade fever at hour 8; This is a spontaneous report from a contactable physician reporting for him/herself via Pfizer sales representative. This patient of unknown age and gender received on an unknown date a single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient noted soreness at injection site at hour 3, and low grade fever at hour 8. Outcome was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain
Clinical narrative: numbness in my 'ear'/numbness in my hands; Numbness in the beginning and right now numbness and pain; right now numbness and pain; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date unknown), via an unspecified route of administration on 18Dec2020 at 15:00 at single dose for COVID-19 immunization (just got the vaccine). The patient's medical history and concomitant medications were not reported. The patient reported that she just got the vaccine today (18Dec2020) and she took it in her hospital, she felt numbness in her 'ear', her hands and right now going through the pain. Patient reported that numbness in the beginning and right now numbness and pain. She got the vaccine exactly at 3O'clock (15:00) and after20-25 minutes later, she started feeling numbness and pain. She did have pain right now. She had not taken anything as treatment. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Feeling cold, Nausea, Skin warm
Clinical narrative: Recently feeling chilly; I just feel very nauseous and weaken like my body some parts are hot and some parts are cold; I just feel very nauseous and weaken like my body some parts are hot and some parts are cold; weaken like my body some parts are hot and some parts are cold; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (reported as COVID Vaccine, lot number and expiration date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the COVID Vaccine and had been recently feeling chilly and also just really weak and nauseous and patient guessed just never felt this way before. The patient know that they were side effects but just felt very nauseous and weaken like the patient's body some parts were hot and some parts were cold. The outcome of events was unknown. Information regarding lot/batch has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: allergic reaction; This is a spontaneous report from a contactable physician.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced allergic reaction in Dec2020.  No further details were provided.  The outcome of allergic reaction was unknown.    The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event allergic reaction due to temporal association. However patient past medical history regarding allergy would have been helpful for a meaningful causality assessment. Case will be reevaluated upon further information
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: patient did that and was sick for a week; Initial information was received on 06-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient).  This case involves a patient of unknown age who did that and was sick for a week (illness), while patient was treated with influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site.   On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient did that and was sick for a week (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
Age: 0.17
Sex: U
Vaccine: DTAPHEPBIP, DTAPIPVHIB
Symptoms: Extra dose administered, No adverse event
Clinical narrative: 2 month old patient received both vaccines Pentacel and  Pediarix, no AE; Initial information received on 05-Nov-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a two month old patient who received vaccines DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and DIPHTHERIA VACCINE TOXOID, HEPATITIS B VACCINE RHBSAG (YEAST), PERTUSSIS VACCINE ACELLULAR 3-COMPONENT, POLIO VACCINE INACT 3V (VERO), TETANUS VACCINE TOXOID [PEDIARIX] (extra dose administered).  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.  On an unknown date, the patient received a dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot UJ342AA and expiry date: 22-Jun-2021) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient received a dose of suspect PEDIARIX not produced by Sanofi Pasteur (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  It was a case of actual medication error due to extra dose administered (latency on same day).  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Muscle tightness, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Swelling of Right arm below the elbow not at the injection site. Soreness and tightness of the right hand. After 72 hours these symptoms resolved however on 12/19/2020 developed burning and itchy hives over abdomen, back and trunk. On 12/21/2020 the hives developed on the scalp.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Swelling of Right arm below the elbow not at the injection site. Soreness and tightness of the right hand. After 72 hours these symptoms resolved however on 12/19/2020 developed burning and itchy hives over abdomen, back and trunk. On 12/21/2020 the hives developed on the scalp.
Sex: M
Vaccine: TDAP
Symptoms: Pertussis, Vaccination failure
Clinical narrative: suspected vaccination failure; whooping cough; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and whooping cough were unknown.   It was unknown if the reporter considered the vaccination failure and whooping cough to be related to DTPa vaccine.  Additional details were provided as follows: The age at vaccination was not applicable. The patient got DPT vaccination. The shot gave him whooping cough and he gave it to his mother and reporter. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for whooping cough and exact time to onset were unknown.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose 02Nov2020 / Second dose 07Dec2020; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too short in a 55-year-old male patient who received Herpes zoster (Shingrix) (batch number 5CB4K, expiry date unknown) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 7th December 2020, the patient received the 2nd dose of Shingrix. On 7th December 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The patient received 2nd dose of Shingrix, before than the recommended interval, which led to shortening of vaccination schedule. The reporter consent to follow up.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Fatigue, Pain
Clinical narrative: Low-grade temperature ranging from 99.8-100.3; chills; body aches; fatigue; This is a spontaneous report from a non-contactable nurse (patient). An adult female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), intramuscular on the right arm on 16Dec2020 18:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 17Dec2020 05:00, the patient experienced low-grade temperature ranging from 99.8-100.3, chills, body aches, and fatigue. No treatment was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. The events were considered non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Chest discomfort, Dyspnoea, Feeling abnormal, Headache
Clinical narrative: bronchitis or pneumonia; pain down arm into fingers; injection site tingling; Chest felt heavy and difficulty breathing; Chest felt heavy and difficulty breathing; bronchitis or pneumonia; rash on both arms with bright purple skin; rash on both arms with bright purple skin; felt like everything was numb and like she was on drugs; felt like everything was numb and like she was on drugs; Severe headache; This is a spontaneous report from a contactable consumer (nurse) via a Pfizer sales representative.  A female patient of an unspecified age received the first dose of the bnt162b2 (BNT162B2; also reported as COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: bronchitis or pneumonia (medically significant), pain down arm into fingers, injection site tingling, chest felt heavy and difficulty breathing, rash on both arms with bright purple skin, felt like everything was numb and like she was on drugs, and severe headache; all of which required hospitalization. The clinical course was reported as follows: The female patient (nurse) took the first dose of the vaccine and experienced pain down arm into fingers, injection site tingling. The patient's chest felt heavy and difficulty breathing; however, the "tongue never swelled." Rapid response was called, and the patient was taken to the hospital. The patient was given a "cocktail" to treat the reaction. The patient "felt like everything was numb and like she was on drugs" The patient also felt like she had bronchitis or pneumonia. The patient also experienced a "rash on both arms with bright purple skin"; along with a severe headache. Therapeutic measures were taken as a result of pain down arm into fingers, injection site tingling, and chest felt heavy and difficulty breathing. The clinical outcome of the events was unknown.  No follow-up attempt possible; information about batch/lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site paraesthesia, Pain in extremity, Pneumonia, Rash
Clinical narrative: bronchitis or pneumonia; pain down arm into fingers; injection site tingling; Chest felt heavy and difficulty breathing; Chest felt heavy and difficulty breathing; bronchitis or pneumonia; rash on both arms with bright purple skin; rash on both arms with bright purple skin; felt like everything was numb and like she was on drugs; felt like everything was numb and like she was on drugs; Severe headache; This is a spontaneous report from a contactable consumer (nurse) via a Pfizer sales representative.  A female patient of an unspecified age received the first dose of the bnt162b2 (BNT162B2; also reported as COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: bronchitis or pneumonia (medically significant), pain down arm into fingers, injection site tingling, chest felt heavy and difficulty breathing, rash on both arms with bright purple skin, felt like everything was numb and like she was on drugs, and severe headache; all of which required hospitalization. The clinical course was reported as follows: The female patient (nurse) took the first dose of the vaccine and experienced pain down arm into fingers, injection site tingling. The patient's chest felt heavy and difficulty breathing; however, the "tongue never swelled." Rapid response was called, and the patient was taken to the hospital. The patient was given a "cocktail" to treat the reaction. The patient "felt like everything was numb and like she was on drugs" The patient also felt like she had bronchitis or pneumonia. The patient also experienced a "rash on both arms with bright purple skin"; along with a severe headache. Therapeutic measures were taken as a result of pain down arm into fingers, injection site tingling, and chest felt heavy and difficulty breathing. The clinical outcome of the events was unknown.  No follow-up attempt possible; information about batch/lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: bronchitis or pneumonia; pain down arm into fingers; injection site tingling; Chest felt heavy and difficulty breathing; Chest felt heavy and difficulty breathing; bronchitis or pneumonia; rash on both arms with bright purple skin; rash on both arms with bright purple skin; felt like everything was numb and like she was on drugs; felt like everything was numb and like she was on drugs; Severe headache; This is a spontaneous report from a contactable consumer (nurse) via a Pfizer sales representative.  A female patient of an unspecified age received the first dose of the bnt162b2 (BNT162B2; also reported as COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: bronchitis or pneumonia (medically significant), pain down arm into fingers, injection site tingling, chest felt heavy and difficulty breathing, rash on both arms with bright purple skin, felt like everything was numb and like she was on drugs, and severe headache; all of which required hospitalization. The clinical course was reported as follows: The female patient (nurse) took the first dose of the vaccine and experienced pain down arm into fingers, injection site tingling. The patient's chest felt heavy and difficulty breathing; however, the "tongue never swelled." Rapid response was called, and the patient was taken to the hospital. The patient was given a "cocktail" to treat the reaction. The patient "felt like everything was numb and like she was on drugs" The patient also felt like she had bronchitis or pneumonia. The patient also experienced a "rash on both arms with bright purple skin"; along with a severe headache. Therapeutic measures were taken as a result of pain down arm into fingers, injection site tingling, and chest felt heavy and difficulty breathing. The clinical outcome of the events was unknown.  No follow-up attempt possible; information about batch/lot number cannot be obtained.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received bnt162b2 (BNT162B2, lot number: EH9899), via an unspecified route of administration on the left arm on 17Dec2020 10:45 at a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19 (patient was diagnosed with COVID-19 prior to vaccination). Concomitant medications included ascorbic acid, biotin, calcium carbonate, calcium pantothenate, calcium phosphate dibasic, chromium picolinate, colecalciferol, copper sulfate, cyanocobalamin, ferrous fumarate, folic acid, magnesium borate, magnesium oxide, manganese sulfate, nickel sulfate, nicotinamide, panax ginseng root, phytomenadione, potassium chloride, potassium iodide, pyridoxine hydrochloride, retinol acetate, riboflavin, sodium metavanadate, sodium molybdate, sodium selenate, stannous chloride, thiamine mononitrate, tocopheryl acetate, zinc oxide (CENTRUM ENERGY), and pantoprazole sodium sesquihydrate (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]). On 17Dec2020 13:00, the patient experienced chills, severe headache, joint pain, muscle aches. Therapeutic measure was not given as a result of the events. Clinical outcome of the events was not recovered.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Illness, Myalgia, Nausea
Clinical narrative: Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received bnt162b2 (BNT162B2, lot number: EH9899), via an unspecified route of administration on the left arm on 17Dec2020 10:45 at a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19 (patient was diagnosed with COVID-19 prior to vaccination). Concomitant medications included ascorbic acid, biotin, calcium carbonate, calcium pantothenate, calcium phosphate dibasic, chromium picolinate, colecalciferol, copper sulfate, cyanocobalamin, ferrous fumarate, folic acid, magnesium borate, magnesium oxide, manganese sulfate, nickel sulfate, nicotinamide, panax ginseng root, phytomenadione, potassium chloride, potassium iodide, pyridoxine hydrochloride, retinol acetate, riboflavin, sodium metavanadate, sodium molybdate, sodium selenate, stannous chloride, thiamine mononitrate, tocopheryl acetate, zinc oxide (CENTRUM ENERGY), and pantoprazole sodium sesquihydrate (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]). On 17Dec2020 13:00, the patient experienced chills, severe headache, joint pain, muscle aches. Therapeutic measure was not given as a result of the events. Clinical outcome of the events was not recovered.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: Injection site pain; Fatigue; This is a spontaneous report from a contactable healthcare professional. A 50-year-old female patient received bnt162b2 (BNT162B2, lot number: EK5730), intramuscular on the left arm on 17Dec2020 09:00 at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 18Dec2020, the patient experienced injection site pain and fatigue. Therapeutic measure was not given as a result of the events. Clinical outcome of the events was recovering.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Arm soreness; fatigue; This is a spontaneous report from a contactable consumer.   A 23-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at right arm on 18Dec2020 08:00 for immunization, administered at hospital.  The patient medical history was not reported. No known allergies. Concomitant medication included MultiVitamins and colecalciferol (VITAMIN D [COLECALCIFEROL]). The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced arm soreness and fatigue on 18Dec2020 11:00. The patient has received not treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The action taken in response to the events for bnt162b2 was not applicable. The outcome of events was recovering.  Information on the lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth, Feeling abnormal
Clinical narrative: mild dry mouth; felt a little foggy; This is a spontaneous report from contactable consumer via a Pfizer Sales Representative. A 52-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 18Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild dry mouth and felt a little foggy on 18Dec2020. The clinical outcome of mild dry mouth and felt a little foggy was recovered on 18Dec2020.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: sick; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.    This case involves patient (unknown demography) who had the flu (influenza), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site.    On an unknown date, the patient developed non-serious had the flu (influenza intensity-mild) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported. It was not reported if the patient received any corrective treatment. At the time of report, the outcome was unknown for the event. There will be no information available on the batch number for this case.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: 100.5 fever/chills, body aches. Treated with ibuprofen. Resolved within 24hrs of vaccine.
Age: 68.0
Sex: F
Vaccine: FLU4
Symptoms: Electromyogram, Injection site pain, Nerve conduction studies, Pain in extremity, X-ray limb
Clinical narrative: Patient disclosed during a telemedicine visit on 12/22/2020 that she has had tenderness at injection site, tenderness over her left shoulder and radiating pain down arm into her left hand since receiving the vaccine on 10/07/2020.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rash, Skin swelling
Clinical narrative: One day after vaccination, patient returned to the injection clinic and reported noticed shoulder and arm swelling with a patchy rash to her R shoulder.  Symptoms resolved. She was advised to call the call center and f/u with PCP.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Urticaria
Clinical narrative: Urticaria, tachycardia at 10 minutes post injection in left arm and neck Treated with oral cetirizine and montelukast. Resolved within 15 minutes of treatment. Discharged in good condition with PO diphenhydramine as needed.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Hypersomnia, Nausea, Pain
Clinical narrative: Headache, explosive diarrhea, nausea & vomiting, fever, slept for 18 hours, body aches
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Headache, explosive diarrhea, nausea & vomiting, fever, slept for 18 hours, body aches
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: Patient recieved dose one of the Pfizer Covid 19 Vaccine.  Within ten minutes scratchy throat started.  Patient was monitored for 30 minutes and throat irritation became worse. Transferred to urgent care for follow up. Received a dose of diphenhyramine, symptoms lessened, and was able to leave urgent care for home.
Age: 77.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: It appears it was given very posterior (possibly sub Q).  Has a large knot, large area of warmth and erythema, appx 15 cm
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide normal, Chest X-ray abnormal, Dizziness, Electrocardiogram normal, Full blood count normal
Clinical narrative: Patient developed dizziness shortly after receiving Pfizer Covid-19 vaccine on 12/21/2020.  Patient was brought to the Emergency Department.  SBP initially in 70's, rapidly improved to 90's without intervention.  Patient denied SOB.  No e/o angioedema on exam.  SBP improved to 110's after 500cc of NS.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test normal, Troponin normal
Clinical narrative: Patient developed dizziness shortly after receiving Pfizer Covid-19 vaccine on 12/21/2020.  Patient was brought to the Emergency Department.  SBP initially in 70's, rapidly improved to 90's without intervention.  Patient denied SOB.  No e/o angioedema on exam.  SBP improved to 110's after 500cc of NS.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Loss of personal independence in daily activities, Nausea, Pain
Clinical narrative: Body aches, and fatigue started 6 hours after vaccine administered. The next day I had a moderate headache that I took ibuprofen, and Tylenol for. Body aches, and fatigue continued the next day. It was difficult for me to participate in ADL's. Headache, nausea, and fatigue continued to two days post vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Joint swelling, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever, Chills, swollen joints
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA  metallic taste immediately following 1st IM dose
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pain, Pain in extremity
Clinical narrative: While driving home after receiving the vaccine I was very close to losing consciousness.  After laying down in my car for 20 minutes I was able to drive home.  I developed a headache that did not subside fully until three days later.  On Friday December 18th, I woke up with a very sore arm, from my shoulder to my wrist, I still had a headache, developed; fever, chills, body aches, and nausea.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope, Pyrexia
Clinical narrative: While driving home after receiving the vaccine I was very close to losing consciousness.  After laying down in my car for 20 minutes I was able to drive home.  I developed a headache that did not subside fully until three days later.  On Friday December 18th, I woke up with a very sore arm, from my shoulder to my wrist, I still had a headache, developed; fever, chills, body aches, and nausea.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Influenza virus test negative, Nausea, SARS-CoV-2 test negative
Clinical narrative: Dizziness, headache, nausea started 12/19/20. Vomited on 12/20/20. Came in on 12/21/20 to be seen by provider.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness, headache, nausea started 12/19/20. Vomited on 12/20/20. Came in on 12/21/20 to be seen by provider.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Headache, Nausea
Clinical narrative: Vaccine recipient received vaccine on 12/19/2020.On 12/20 experienced symptoms of headache, fatigue, chills, fever 101.8 F, lower back pain, and nausea. The vaccine recipient took acetaminophen and managed symptoms at home. Reported to have slept for most of the day. On 12/22, during a follow-up phone call reported that most of the symptoms have subsided and only nausea remained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Vaccine recipient received vaccine on 12/19/2020.On 12/20 experienced symptoms of headache, fatigue, chills, fever 101.8 F, lower back pain, and nausea. The vaccine recipient took acetaminophen and managed symptoms at home. Reported to have slept for most of the day. On 12/22, during a follow-up phone call reported that most of the symptoms have subsided and only nausea remained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure systolic increased, Heart rate increased, Palpitations, Tremor
Clinical narrative: Approx 5 minutes after receipt of vaccine, patient reported experiencing palpitations.  Vitals signs were checked and HR elevated to the 130s (regular rhythm) and systolic BP elevated to the 160-170s mmHg;  pulse ox within normal limits.  Some mild tremors noted in left > right hand.   Patient placed in supine position and given 12.5mg IV benadryl and 4mg x2 doses =8mg total IV dexamethasone with symptomatic improvement and normalization of HR / BP.  No hypotension or hypoxia throughout the event.  No angioedema or urticaria.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Epistaxis
Clinical narrative: Employee reported a bloody nose and blood in urine this morning (slight tinge) Has not exhibited any other side effects at the time of this report. Noted in afternoon on 12/18/2020 urinated and no blood present.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Fatigue, Feeling abnormal
Clinical narrative: 1. Day 1- (same day) didn't feel anything until later that night, I felt a lump at site with a quarter size area around the direct shot red and sore. 2. Day 2- Sore arm, felt a bit restricted to move arm around, minor weakness, still red quarter size and lump at site. 3. Day 3- Arm same as day 2, but by the evening I was extremely tired. Joint pains, body aches, and random chills all severe. 4. Day 4- Arm issues gone but continued with the body aches, weakness, extremely tired, and chills. A bit cloudy, and a bit forgetful. 5. Day 5- Same as day 4, but worse. Completely unable to accomplish daily activities, had to call in to work, weakness at one point as bad as struggling to lift and open a water bottle. 6. Day 6- I am here, slightly better than the day before. Still severe joint pains, body aches, and body chills.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Grip strength decreased, Impaired work ability, Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: 1. Day 1- (same day) didn't feel anything until later that night, I felt a lump at site with a quarter size area around the direct shot red and sore. 2. Day 2- Sore arm, felt a bit restricted to move arm around, minor weakness, still red quarter size and lump at site. 3. Day 3- Arm same as day 2, but by the evening I was extremely tired. Joint pains, body aches, and random chills all severe. 4. Day 4- Arm issues gone but continued with the body aches, weakness, extremely tired, and chills. A bit cloudy, and a bit forgetful. 5. Day 5- Same as day 4, but worse. Completely unable to accomplish daily activities, had to call in to work, weakness at one point as bad as struggling to lift and open a water bottle. 6. Day 6- I am here, slightly better than the day before. Still severe joint pains, body aches, and body chills.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Loss of personal independence in daily activities, Memory impairment, Mobility decreased, Pain
Clinical narrative: 1. Day 1- (same day) didn't feel anything until later that night, I felt a lump at site with a quarter size area around the direct shot red and sore. 2. Day 2- Sore arm, felt a bit restricted to move arm around, minor weakness, still red quarter size and lump at site. 3. Day 3- Arm same as day 2, but by the evening I was extremely tired. Joint pains, body aches, and random chills all severe. 4. Day 4- Arm issues gone but continued with the body aches, weakness, extremely tired, and chills. A bit cloudy, and a bit forgetful. 5. Day 5- Same as day 4, but worse. Completely unable to accomplish daily activities, had to call in to work, weakness at one point as bad as struggling to lift and open a water bottle. 6. Day 6- I am here, slightly better than the day before. Still severe joint pains, body aches, and body chills.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: 1. Day 1- (same day) didn't feel anything until later that night, I felt a lump at site with a quarter size area around the direct shot red and sore. 2. Day 2- Sore arm, felt a bit restricted to move arm around, minor weakness, still red quarter size and lump at site. 3. Day 3- Arm same as day 2, but by the evening I was extremely tired. Joint pains, body aches, and random chills all severe. 4. Day 4- Arm issues gone but continued with the body aches, weakness, extremely tired, and chills. A bit cloudy, and a bit forgetful. 5. Day 5- Same as day 4, but worse. Completely unable to accomplish daily activities, had to call in to work, weakness at one point as bad as struggling to lift and open a water bottle. 6. Day 6- I am here, slightly better than the day before. Still severe joint pains, body aches, and body chills.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site pruritus
Clinical narrative: Pfizer-BioNTech COVID-19 Vaccine EUA  immediately after 1st IM dose pt experienced itching at injection site, itching resolved with 10 minutes
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: anaphylaxis
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Pallor, Palpitations
Clinical narrative: Employee stated she felt her heart racing and felt "off." Appeared to RN to be diaphoretic and pale but remained alert, oriented, speaking full sentences no shortness of breath, scratchy throat or rash. 50mg Benadryl PO at 06:25am. Highly encouraged patient to stay for additional 15 minutes. Patient refused to stay stating she didn't have childcare beyond 7am. Instructions given to patient re: symptoms to monitor for and to seek medical assistance if symptoms worsened or persisted. Additionallyasked patient to contact employee health.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: injection site soreness and slight swelling.  chills, fever 99 F
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Myalgia, Nausea, Pyrexia
Clinical narrative: Extreme swelling of lymph nodes on left side of body (specifically armpit) Fever Muscle Pain Swelling Headache Nausea Vomiting
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vomiting
Clinical narrative: Extreme swelling of lymph nodes on left side of body (specifically armpit) Fever Muscle Pain Swelling Headache Nausea Vomiting
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Pain
Clinical narrative: After the injection I stayed on a recliner for 15 min before returning to work, nothing happened, I felt good. After I arrived home, about 3 hours later when I was home I felt a mild headache. The next day I felt muscle pains/body aches, specially on the right side of my body, my right shoulder was hurting really bad. after 48 hours the symptoms went away.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased
Clinical narrative: 12/21/2020- 1 called with increased BP 12 hours after vaccination. Was seen by MD and went to ER. Med for BP increased and modified until stable.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Palpitations, Tachycardia, Throat tightness
Clinical narrative: Patient describes flushing, upon examination: "heart was pounding in my head".  Patient felt like she was going to "pass out". and "throat fullness"  Medical team reported patient was tachycardic .  Administered 25mg (oral) benadryl X1 Alerted covering physician (per protocol)
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Pharyngeal erythema, Pharyngeal swelling, Pruritus, Urticaria
Clinical narrative: Approximately 20 minutes following COVID-19 vaccination the patient suddenly developed hives, itching - Hives around face and upper chest. Throat was red and slightly swollen. Was brought to the Emergency Department within out hospital for assessment and medical care.  Acute treatment included methylprednisolone 125 mg IV x 1 dose, diphenhydramine 50 mg IV x 1 dose, epinephrine 0.3 mg IM x 1 dose, and famotidine 20 mg IV x 1 dose. The patient felt better following this treatment  Upon reassessment oropharyngeal swelling had improved, the patient no longer had hives and the throat appeared clear. The patient stated he no longer feels itchy but does feel a little short of breath. Lungs were clear with  pulse oximetry 97%.
Age: 0.33
Sex: F
Vaccine: HIBV
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Redness and bumps covering the side of the thigh where immunization was given
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Orthostatic hypotension
Clinical narrative: Felt lightheaded upon standing and stated " my body felt whooshy "; HR-52-- baseline and remained alert and oriented x3; Benadryl 25 mg given --observed patient for 30 minutes; ambulated patient and she stated she felt fine--funny feeling gone
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Myalgia, Pain
Clinical narrative: Fever, Fatigue, Weakness, Body Aches, Chills, Muscle Pains lasting until Monday 12/21/2020
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever, Fatigue, Weakness, Body Aches, Chills, Muscle Pains lasting until Monday 12/21/2020
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Patient expereinced pain at vaccination site 2 hours after administration.  in 20 hours it had become red and swollen.  Swelling and redness have steadily decreased to time of individual reporting today at 13:00 (Jan 22, 2020 reported)
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Flushing, Heart rate increased, Tachycardia
Clinical narrative: Ten minutes after vaccine was injected pt started having elevated heart rate and mild flushing.. She was sent to the emergency department for clinical evaluation and further observation. She refused medication while at the vaccination site.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood thyroid stimulating hormone normal, Flushing, Headache, Heart rate increased, Tachycardia
Clinical narrative: Ten minutes after vaccine was injected pt started having elevated heart rate and mild flushing.. She was sent to the emergency department for clinical evaluation and further observation. She refused medication while at the vaccination site.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Valsalva maneuver
Clinical narrative: Ten minutes after vaccine was injected pt started having elevated heart rate and mild flushing.. She was sent to the emergency department for clinical evaluation and further observation. She refused medication while at the vaccination site.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous
Clinical narrative: Patient reported to the pharmacist that when she received her first Shingrix dose 3 months before, that she broke out in a rash all over her body. She described the rash as red bumps. The patient alerted her PCP to the issue and the rash resolved. Patient could not remember the exact date the rash started or how long it lasted.
Age: 61.0
Sex: M
Vaccine: FLU4, VARZOS
Symptoms: Dermatitis contact, Skin disorder
Clinical narrative: pt stated after receiving the shingrix vaccine both shot 1 and shot 2 he got contact dermatitis and another skin affliction requiring him to visit his dermatologist. He noticed this after both shingrix shots.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Migraine
Clinical narrative: Migraine headaches chills diarrhea
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Myalgia
Clinical narrative: About 12 hours afterward the initial injection (0330) I began feeling very cold, started shivering violently to the point where I seemed to feel like I was a Parkinson's patient and nearly froze my jaw with severe muscle aches. Was able to calm the symptoms after standing by a hot oven.  Only reason I'm fairly certain this was some kind of reaction as I had a similar event happen when when I last got a tetanus shot 14 years ago where I was in the ER overnight, staff at the vaccine clinic even held me for a longer period (30 minutes)  then other due to that issue and were given full disclosure of prior events before receiving the injection .  I was diagnosed with Covid 19 on 12/10/20 (They discussed giving the injection with a health dept worker before giving it to me and declared it ok)  and troughout the entirety of my quarantine I have never experienced something like that.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Paraesthesia oral
Clinical narrative: Patient developed mild lightheadedness and tingling of the lips. No SOB, CP, swelling of the throat or lips, or rash. Patient was observed for one hour from vaccine administration. She was given water and crackers. Symptoms improved at 60 minute reevaluation. Vital signs stable. Discharged to home.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Employee reported continuous chills off and on for over 12-24 hours, and major-severe headache.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Chills and headache
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Vaccine recipient reported symptoms of tingling in the tips of index and middle finger on left hand at the time of COVID-19 administration. Symptoms resolved 15 mins later and vaccine recipient continued on with their day with no further issues.
Age: 4.0
Sex: M
Vaccine: FLU4
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Patient with erythema and edema of L leg (almost all of anterior thigh red and swollen) starting 2 days after the vaccine.  Otherwise well.  Patient with h/o similar reaction twice in the past.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site paraesthesia, Paraesthesia
Clinical narrative: She was given the Pfizer vaccination in the left deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience localized tingling at the injection site that radiated into her 4th and 5th digits and proximally along the sternomastoid muscle.  She denied rash, hives, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, dizziness, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area. Monitored patient for severe reaction symptoms, including rapid progression of symptoms, vomiting, hypotension and chest pain. Patient was observed for approximately 30 minutes post injection with no evolution of sx. Injection site tingling that extended along the ulnar nerve distribution was improving at the time of discharge.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Rash, Rash erythematous
Clinical narrative: Day 1-4 large raised bright red injection site warm to touch Day 3 Bright red raised rash all over face and scalp, going down neck
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular
Clinical narrative: Day 1-4 large raised bright red injection site warm to touch Day 3 Bright red raised rash all over face and scalp, going down neck